The IPO is priced in the range of RS 472-496 per share and consists of a new issue of RS 750 Crore, together with an offer for sale (OFS) from RS 89.28 Crore.
Tralt BioEnergy IPO subscription status
From noon, the IPO was subscribed to 8%, according to official share exchange data. Non-Institutional Investors (NIIS): This segment, which includes high-net people and others, was subscribed to 9%.
Retail investors: the retail trade was 12% subscribed to the 61.91 LAKH shares reserved for this category.
Qualified institutional buyers (QIBS): No bids have been received from institutional investors for the 35.10 Lakh shares assigned to them. Qibs usually participates in the last day of the issue, which is September 29 in this case.
Tralt BioEnergy IPO GMP today
Tralt BioEnergy IPO is currently being traded against a Gray Market Premium (GMP) of around 16.2%, or RS 80, as a result of mild investor optimism about the potential performance of the share on the list day. Today’s GMP indicates that the stock could mention with approximately RS 576 per share.
Note: The Gray Market Premium (GMP) is an unofficial indicator of the price of a share before the official list. Because it works in a non -regulated and non -the aforementioned market, GMP values can be volatile and must be carefully interpreted.
Tralt BioEnergy IPO -key details
The subscription window will remain open for three days, from Thursday 25 September 2025 to Monday 29 September 2025. The provisional allocation date is scheduled for Friday, October 3, 2025 with the provisional list.
Company overview
Tralt BioEnergy is one of the largest ethanol producers in India, with an installed capacity of 2,000 kilos of liters per day (KLPD), which represents a market share of 3.6% from FY25.
The company operates five distilleries in Karnataka, four of which use molasses and syrup -based raw materials. It is also diversified in compressed biogas (CBG) through his subsidiary and is investigating new verticals, including Ethanol of the second generation, sustainable aviation fuel and biochemicals.
Financial performance
Financially, Tralt BioEnergy has reported a robust growth. Turnover increased by 54% on an annual basis to RS 1,968.53 Crore in FY25, while profit after the tax rose more than four -time to RS 146.64 crore from RS 31.81 crore in FY24. EBITDA was on RS 309.14 Crore in FY25, an increase in RS 188.09 Crore a year earlier.
The net debt of the company rose to RS 1,400 crore in FY25 from RS 1,145 Crore in FY23, which reflects the continuous capacity expansion and investments. Although the net debt / equity ratio fell to 1.8 in FY25 of 6.3 in FY24, it remains higher than the typical reach of 0.6-0.8 for some colleagues.
Use of IPO yield
The proceeds from the new issue will mainly be used to finance capital expenditures of RS 150.7 Crore for setting up multi-feedstock operations at the 300 KLPD EThanolfabriek of Tralt Bio-Energy in Karnataka. A large part, RS 425 Crore, will be allocated for working capital requirements, while the rest will be used for general business purposes.
((Indemnification: Recommendations, suggestions, views and opinions of the experts are their own. These do not represent the views of economic times)
#Tralt #BioEnergy #IPO #day #issue #subscribed #Check #GMP #important #details

